Share
Wharton Business Daily
Oxycontin Lawsuit: Massachusetts Sues Sackler Family
In 2017 there were over 47,000 opioid-linked deaths in the United States – a six percent increase from 2016, according to the Centers for Disease Control and Prevention. Massachusetts is now suing Purdue Pharma, maker of Oxycontin, and members of the Sackler family, one of the wealthiest families in America and owners of Purdue Pharma. The suit alleges the Sacklers made billions of dollars as their company pushed doctors to prescribe the pain killer, assuring the drug had a low risk of misuse, even though they knew it was highly addictive. Purdue is also accused of failing to report doctors who were overprescribing the drug. The company is facing hundreds of different suits by state and local governments across the country. Host Dan Loney is joined by Rob Field, Professor of Law and Professor of Health Management and Policy at Drexel University and a lecturer in the Health Care Management Department of the Wharton school, and Keith Humphreys, Professor and Section Director for Mental Health Policy at Stanford University and Senior Research Career Scientist at the VA Health Services Research Center, to discuss these allegations and more on the opioid epidemic on Knowledge@Wharton.
More episodes
View all episodes
How Much is ESG Impacting Bottom Lines? New Research Attempts to Answer Question
11:46Sergeui Netessine, Wharton's Vice Dean for Innovation & Global Initiatives, joins the show to discuss his research on how an emphasis on ESG impacts a company's value.WebMD CMO: The Pandemic Accelerated Technological Changes in Healthcare
09:05John Whyte, WebMD Chief Medical Officer, joins the show to talk about how the pandemic accelerated the use of telemedicine.This interview originally aired as part of Wharton Business Daily's Business of Healthcare special.Basel III Endgame Political Lobbying Efforts in US Have Been Remarkable Says Wharton Professor
09:35David Zaring, Wharton Professor of Legal Studies & Business Ethics, joins the show to discuss Basel III endgame rules and implementation.Sophia Opatska on Running a University in a War Zone
13:06Sophia Opatska, Vice Rector of Strategic Development at Ukrainian Catholic University, joins the show to discuss teaching and running a college in a war zone, as well as the state of business in Ukraine.When and Why Consumers Love Bad Options
10:17New research from Wharton’s Patti Williams tackles one of the biggest contradictions in consumer behavior: why we love stuff that’s so bad, it’s good.Why Startup Accelerators Are an Engine for Economic Growth
04:44Valentina Assenova, Wharton Assistant Professor of Management, recently joined the show to discuss the impact of accelerator programs on startups.Mastercard is Encouraging Consumers to Make More Sustainable Choices: Here's How
10:56Ellen Jackowski, Chief Sustainability Officer with Mastercard, joins the show to discuss climate change, sustainability, and how the company is encouraging consumers to make more sustainable choices. This interview originally aired as part of Wharton Business Daily's Business of Sustainability special.How Do We Control the Rising Costs of Health Care?
09:31Wharton Professor of Health Care Management Lawton Robert Burns joins the show to talk about tactics that can be used to lower drug prices and why there is no silver bullet in terms of controlling the rising costs of health care.Employees Have Specific Expectations Around Inclusive Work Environments & Culture
10:30Dawn Jones, Chief Diversity and Inclusion Officer and Vice President of Social Impact at Intel, joins the show to discuss DEI in the workplace and specifically in the technology industry. This interview originally aired as part of Wharton Business Daily's DEI special.